nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—ABCB1—Methylprednisolone—multiple sclerosis	0.0473	0.115	CbGbCtD
Boceprevir—CYP3A4—Fingolimod—multiple sclerosis	0.044	0.107	CbGbCtD
Boceprevir—ABCB1—Mitoxantrone—multiple sclerosis	0.0345	0.0841	CbGbCtD
Boceprevir—ABCB1—Betamethasone—multiple sclerosis	0.0308	0.075	CbGbCtD
Boceprevir—ABCB1—Prednisolone—multiple sclerosis	0.0304	0.074	CbGbCtD
Boceprevir—ABCB1—Prednisone—multiple sclerosis	0.0287	0.0699	CbGbCtD
Boceprevir—CYP3A4—Methylprednisolone—multiple sclerosis	0.0283	0.0691	CbGbCtD
Boceprevir—CYP3A5—Dexamethasone—multiple sclerosis	0.0275	0.067	CbGbCtD
Boceprevir—CYP3A4—Triamcinolone—multiple sclerosis	0.0215	0.0524	CbGbCtD
Boceprevir—CYP3A4—Mitoxantrone—multiple sclerosis	0.0207	0.0504	CbGbCtD
Boceprevir—CYP3A4—Betamethasone—multiple sclerosis	0.0184	0.0449	CbGbCtD
Boceprevir—CYP3A4—Prednisolone—multiple sclerosis	0.0182	0.0443	CbGbCtD
Boceprevir—ABCB1—Dexamethasone—multiple sclerosis	0.0179	0.0436	CbGbCtD
Boceprevir—CYP3A4—Prednisone—multiple sclerosis	0.0172	0.0419	CbGbCtD
Boceprevir—CTSK—leg—multiple sclerosis	0.0164	0.167	CbGeAlD
Boceprevir—ABCB1—Methotrexate—multiple sclerosis	0.0144	0.035	CbGbCtD
Boceprevir—CYP3A4—Dexamethasone—multiple sclerosis	0.0107	0.0261	CbGbCtD
Boceprevir—CTSL—retina—multiple sclerosis	0.0049	0.0499	CbGeAlD
Boceprevir—CTSV—medulla oblongata—multiple sclerosis	0.00433	0.0442	CbGeAlD
Boceprevir—CTSV—midbrain—multiple sclerosis	0.00396	0.0404	CbGeAlD
Boceprevir—CTSV—spinal cord—multiple sclerosis	0.00387	0.0394	CbGeAlD
Boceprevir—CTSK—retina—multiple sclerosis	0.00369	0.0376	CbGeAlD
Boceprevir—CTSL—medulla oblongata—multiple sclerosis	0.00354	0.0361	CbGeAlD
Boceprevir—CTSV—nervous system—multiple sclerosis	0.00326	0.0332	CbGeAlD
Boceprevir—CTSL—midbrain—multiple sclerosis	0.00324	0.033	CbGeAlD
Boceprevir—CTSS—retina—multiple sclerosis	0.00323	0.033	CbGeAlD
Boceprevir—CTSL—spinal cord—multiple sclerosis	0.00316	0.0322	CbGeAlD
Boceprevir—CTSV—central nervous system—multiple sclerosis	0.00314	0.032	CbGeAlD
Boceprevir—Telaprevir—ALB—multiple sclerosis	0.00276	1	CrCbGaD
Boceprevir—CTSK—medulla oblongata—multiple sclerosis	0.00267	0.0272	CbGeAlD
Boceprevir—CTSL—nervous system—multiple sclerosis	0.00266	0.0271	CbGeAlD
Boceprevir—CTSL—central nervous system—multiple sclerosis	0.00256	0.0261	CbGeAlD
Boceprevir—CTSL—cerebellum—multiple sclerosis	0.0025	0.0255	CbGeAlD
Boceprevir—CTSV—brain—multiple sclerosis	0.00249	0.0254	CbGeAlD
Boceprevir—CTSK—spinal cord—multiple sclerosis	0.00238	0.0243	CbGeAlD
Boceprevir—CTSS—medulla oblongata—multiple sclerosis	0.00234	0.0238	CbGeAlD
Boceprevir—CTSS—midbrain—multiple sclerosis	0.00214	0.0218	CbGeAlD
Boceprevir—CTSS—spinal cord—multiple sclerosis	0.00208	0.0212	CbGeAlD
Boceprevir—CTSL—brain—multiple sclerosis	0.00203	0.0207	CbGeAlD
Boceprevir—CTSK—nervous system—multiple sclerosis	0.002	0.0204	CbGeAlD
Boceprevir—CTSK—central nervous system—multiple sclerosis	0.00193	0.0197	CbGeAlD
Boceprevir—CTSK—cerebellum—multiple sclerosis	0.00189	0.0192	CbGeAlD
Boceprevir—CTSS—nervous system—multiple sclerosis	0.00176	0.0179	CbGeAlD
Boceprevir—CTSS—central nervous system—multiple sclerosis	0.00169	0.0172	CbGeAlD
Boceprevir—CTSS—cerebellum—multiple sclerosis	0.00165	0.0168	CbGeAlD
Boceprevir—CTSK—brain—multiple sclerosis	0.00153	0.0156	CbGeAlD
Boceprevir—CTSS—brain—multiple sclerosis	0.00134	0.0137	CbGeAlD
Boceprevir—CTSL—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.000764	0.114	CbGdCrCtD
Boceprevir—CTSL—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.000752	0.113	CbGdCrCtD
Boceprevir—CTSL—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.000752	0.113	CbGdCrCtD
Boceprevir—CTSL—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.000735	0.11	CbGdCrCtD
Boceprevir—ABCB1—retina—multiple sclerosis	0.00057	0.00582	CbGeAlD
Boceprevir—CYP3A4—nervous system—multiple sclerosis	0.000438	0.00446	CbGeAlD
Boceprevir—CYP3A4—central nervous system—multiple sclerosis	0.000421	0.0043	CbGeAlD
Boceprevir—ABCB1—medulla oblongata—multiple sclerosis	0.000412	0.0042	CbGeAlD
Boceprevir—CTSL—Dexamethasone—Methylprednisolone—multiple sclerosis	0.000388	0.058	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Methylprednisolone—multiple sclerosis	0.000388	0.058	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Betamethasone—multiple sclerosis	0.000381	0.0571	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Dexamethasone—multiple sclerosis	0.000381	0.0571	CbGdCrCtD
Boceprevir—ABCB1—midbrain—multiple sclerosis	0.000377	0.00384	CbGeAlD
Boceprevir—CTSL—Dexamethasone—Triamcinolone—multiple sclerosis	0.000373	0.0558	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Triamcinolone—multiple sclerosis	0.000373	0.0558	CbGdCrCtD
Boceprevir—ABCB1—spinal cord—multiple sclerosis	0.000368	0.00375	CbGeAlD
Boceprevir—CTSL—Betamethasone—Prednisone—multiple sclerosis	0.000354	0.0529	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Prednisone—multiple sclerosis	0.000354	0.0529	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Prednisolone—multiple sclerosis	0.000345	0.0516	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Prednisolone—multiple sclerosis	0.000345	0.0516	CbGdCrCtD
Boceprevir—ABCB1—nervous system—multiple sclerosis	0.00031	0.00316	CbGeAlD
Boceprevir—ABCB1—central nervous system—multiple sclerosis	0.000298	0.00304	CbGeAlD
Boceprevir—ABCB1—cerebellum—multiple sclerosis	0.000292	0.00297	CbGeAlD
Boceprevir—ABCB1—brain—multiple sclerosis	0.000237	0.00241	CbGeAlD
Boceprevir—Syncope—Dexamethasone—multiple sclerosis	0.000157	0.000623	CcSEcCtD
Boceprevir—Arrhythmia—Prednisone—multiple sclerosis	0.000157	0.000621	CcSEcCtD
Boceprevir—Infection—Triamcinolone—multiple sclerosis	0.000157	0.000621	CcSEcCtD
Boceprevir—Infection—Methylprednisolone—multiple sclerosis	0.000157	0.00062	CcSEcCtD
Boceprevir—Shock—Triamcinolone—multiple sclerosis	0.000155	0.000615	CcSEcCtD
Boceprevir—Insomnia—Prednisolone—multiple sclerosis	0.000155	0.000615	CcSEcCtD
Boceprevir—Alopecia—Prednisone—multiple sclerosis	0.000155	0.000615	CcSEcCtD
Boceprevir—Shock—Methylprednisolone—multiple sclerosis	0.000155	0.000614	CcSEcCtD
Boceprevir—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000155	0.000612	CcSEcCtD
Boceprevir—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000155	0.000612	CcSEcCtD
Boceprevir—Loss of consciousness—Betamethasone—multiple sclerosis	0.000154	0.000611	CcSEcCtD
Boceprevir—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000154	0.000611	CcSEcCtD
Boceprevir—Epistaxis—Methotrexate—multiple sclerosis	0.000154	0.000611	CcSEcCtD
Boceprevir—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000154	0.000611	CcSEcCtD
Boceprevir—Paraesthesia—Prednisolone—multiple sclerosis	0.000154	0.000611	CcSEcCtD
Boceprevir—Tachycardia—Triamcinolone—multiple sclerosis	0.000154	0.00061	CcSEcCtD
Boceprevir—Mental disorder—Prednisone—multiple sclerosis	0.000154	0.000609	CcSEcCtD
Boceprevir—Nausea—Azathioprine—multiple sclerosis	0.000154	0.000609	CcSEcCtD
Boceprevir—Tachycardia—Methylprednisolone—multiple sclerosis	0.000154	0.000609	CcSEcCtD
Boceprevir—Skin disorder—Methylprednisolone—multiple sclerosis	0.000153	0.000606	CcSEcCtD
Boceprevir—Malnutrition—Prednisone—multiple sclerosis	0.000153	0.000605	CcSEcCtD
Boceprevir—Erythema—Prednisone—multiple sclerosis	0.000153	0.000605	CcSEcCtD
Boceprevir—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000153	0.000604	CcSEcCtD
Boceprevir—Agranulocytosis—Methotrexate—multiple sclerosis	0.000153	0.000604	CcSEcCtD
Boceprevir—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000152	0.000603	CcSEcCtD
Boceprevir—Hypertension—Dexamethasone—multiple sclerosis	0.000152	0.0006	CcSEcCtD
Boceprevir—Hypertension—Betamethasone—multiple sclerosis	0.000152	0.0006	CcSEcCtD
Boceprevir—Asthenia—Mitoxantrone—multiple sclerosis	0.00015	0.000595	CcSEcCtD
Boceprevir—Myalgia—Betamethasone—multiple sclerosis	0.000149	0.000592	CcSEcCtD
Boceprevir—Myalgia—Dexamethasone—multiple sclerosis	0.000149	0.000592	CcSEcCtD
Boceprevir—Anxiety—Dexamethasone—multiple sclerosis	0.000149	0.00059	CcSEcCtD
Boceprevir—Anxiety—Betamethasone—multiple sclerosis	0.000149	0.00059	CcSEcCtD
Boceprevir—Discomfort—Dexamethasone—multiple sclerosis	0.000148	0.000585	CcSEcCtD
Boceprevir—Discomfort—Betamethasone—multiple sclerosis	0.000148	0.000585	CcSEcCtD
Boceprevir—Hypotension—Methylprednisolone—multiple sclerosis	0.000147	0.000583	CcSEcCtD
Boceprevir—Pain—Prednisolone—multiple sclerosis	0.000147	0.000581	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—CD40—multiple sclerosis	0.000146	0.000635	CbGpPWpGaD
Boceprevir—Pharyngitis—Methotrexate—multiple sclerosis	0.000146	0.000577	CcSEcCtD
Boceprevir—CTSS—Immune System—MALT1—multiple sclerosis	0.000145	0.000633	CbGpPWpGaD
Boceprevir—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000145	0.000574	CcSEcCtD
Boceprevir—CTSV—Adaptive Immune System—CD80—multiple sclerosis	0.000145	0.00063	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CD80—multiple sclerosis	0.000145	0.00063	CbGpPWpGaD
Boceprevir—Vision blurred—Prednisone—multiple sclerosis	0.000144	0.000571	CcSEcCtD
Boceprevir—Urethral disorder—Methotrexate—multiple sclerosis	0.000144	0.00057	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000144	0.00057	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	0.000144	0.000626	CbGpPWpGaD
Boceprevir—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000144	0.000568	CcSEcCtD
Boceprevir—CMA1—Extracellular matrix organization—TGFB1—multiple sclerosis	0.000143	0.000625	CbGpPWpGaD
Boceprevir—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000143	0.000567	CcSEcCtD
Boceprevir—CTSS—Immune System—IRF5—multiple sclerosis	0.000143	0.000622	CbGpPWpGaD
Boceprevir—Insomnia—Triamcinolone—multiple sclerosis	0.000143	0.000566	CcSEcCtD
Boceprevir—Insomnia—Methylprednisolone—multiple sclerosis	0.000143	0.000564	CcSEcCtD
Boceprevir—Infection—Betamethasone—multiple sclerosis	0.000142	0.000564	CcSEcCtD
Boceprevir—Infection—Dexamethasone—multiple sclerosis	0.000142	0.000564	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—HLA-A—multiple sclerosis	0.000142	0.000619	CbGpPWpGaD
Boceprevir—Ill-defined disorder—Prednisone—multiple sclerosis	0.000142	0.000562	CcSEcCtD
Boceprevir—Paraesthesia—Triamcinolone—multiple sclerosis	0.000142	0.000561	CcSEcCtD
Boceprevir—Feeling abnormal—Prednisolone—multiple sclerosis	0.000142	0.00056	CcSEcCtD
Boceprevir—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000142	0.00056	CcSEcCtD
Boceprevir—Visual impairment—Methotrexate—multiple sclerosis	0.000141	0.00056	CcSEcCtD
Boceprevir—Anaemia—Prednisone—multiple sclerosis	0.000141	0.00056	CcSEcCtD
Boceprevir—Shock—Dexamethasone—multiple sclerosis	0.000141	0.000558	CcSEcCtD
Boceprevir—Shock—Betamethasone—multiple sclerosis	0.000141	0.000558	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—CD86—multiple sclerosis	0.000141	0.000614	CbGpPWpGaD
Boceprevir—Dyspnoea—Triamcinolone—multiple sclerosis	0.000141	0.000557	CcSEcCtD
Boceprevir—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000141	0.000556	CcSEcCtD
Boceprevir—Nervous system disorder—Betamethasone—multiple sclerosis	0.000141	0.000556	CcSEcCtD
Boceprevir—Agitation—Prednisone—multiple sclerosis	0.000141	0.000556	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—HLA-DQB1—multiple sclerosis	0.00014	0.000612	CbGpPWpGaD
Boceprevir—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.00014	0.000556	CcSEcCtD
Boceprevir—Thrombocytopenia—Betamethasone—multiple sclerosis	0.00014	0.000556	CcSEcCtD
Boceprevir—Tachycardia—Dexamethasone—multiple sclerosis	0.00014	0.000554	CcSEcCtD
Boceprevir—Tachycardia—Betamethasone—multiple sclerosis	0.00014	0.000554	CcSEcCtD
Boceprevir—Angioedema—Prednisone—multiple sclerosis	0.00014	0.000553	CcSEcCtD
Boceprevir—CTSK—Immune System—CD28—multiple sclerosis	0.00014	0.000608	CbGpPWpGaD
Boceprevir—Dyspepsia—Triamcinolone—multiple sclerosis	0.000139	0.00055	CcSEcCtD
Boceprevir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000139	0.000605	CbGpPWpGaD
Boceprevir—Erythema multiforme—Methotrexate—multiple sclerosis	0.000139	0.00055	CcSEcCtD
Boceprevir—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000139	0.000549	CcSEcCtD
Boceprevir—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000139	0.000548	CcSEcCtD
Boceprevir—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000139	0.000548	CcSEcCtD
Boceprevir—Malaise—Prednisone—multiple sclerosis	0.000138	0.000546	CcSEcCtD
Boceprevir—Vertigo—Prednisone—multiple sclerosis	0.000137	0.000544	CcSEcCtD
Boceprevir—Eye disorder—Methotrexate—multiple sclerosis	0.000137	0.000543	CcSEcCtD
Boceprevir—CTSK—Immune System—PTPRC—multiple sclerosis	0.000137	0.000597	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CCR2—multiple sclerosis	0.000137	0.000597	CbGpPWpGaD
Boceprevir—Syncope—Prednisone—multiple sclerosis	0.000137	0.000543	CcSEcCtD
Boceprevir—Tinnitus—Methotrexate—multiple sclerosis	0.000137	0.000542	CcSEcCtD
Boceprevir—CTSS—Immune System—IRF8—multiple sclerosis	0.000137	0.000595	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IFIH1—multiple sclerosis	0.000137	0.000595	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HLA-G—multiple sclerosis	0.000137	0.000595	CbGpPWpGaD
Boceprevir—Urticaria—Prednisolone—multiple sclerosis	0.000136	0.00054	CcSEcCtD
Boceprevir—Cardiac disorder—Methotrexate—multiple sclerosis	0.000136	0.000539	CcSEcCtD
Boceprevir—Fatigue—Triamcinolone—multiple sclerosis	0.000136	0.000539	CcSEcCtD
Boceprevir—Fatigue—Methylprednisolone—multiple sclerosis	0.000136	0.000538	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—CD86—multiple sclerosis	0.000135	0.000589	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—TLR4—multiple sclerosis	0.000135	0.000589	CbGpPWpGaD
Boceprevir—Pain—Triamcinolone—multiple sclerosis	0.000135	0.000535	CcSEcCtD
Boceprevir—Loss of consciousness—Prednisone—multiple sclerosis	0.000134	0.000532	CcSEcCtD
Boceprevir—Hypotension—Betamethasone—multiple sclerosis	0.000134	0.00053	CcSEcCtD
Boceprevir—Hypotension—Dexamethasone—multiple sclerosis	0.000134	0.00053	CcSEcCtD
Boceprevir—CTSL—Immune System—VCAM1—multiple sclerosis	0.000134	0.000583	CbGpPWpGaD
Boceprevir—CTSV—Immune System—VCAM1—multiple sclerosis	0.000134	0.000583	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HLA-DQA1—multiple sclerosis	0.000134	0.000582	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HLA-DQA1—multiple sclerosis	0.000134	0.000582	CbGpPWpGaD
Boceprevir—Angiopathy—Methotrexate—multiple sclerosis	0.000133	0.000527	CcSEcCtD
Boceprevir—Vomiting—Mitoxantrone—multiple sclerosis	0.000133	0.000527	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—CD40LG—multiple sclerosis	0.000133	0.000578	CbGpPWpGaD
Boceprevir—Immune system disorder—Methotrexate—multiple sclerosis	0.000133	0.000525	CcSEcCtD
Boceprevir—CTSK—Immune System—HLA-DPB1—multiple sclerosis	0.000133	0.000577	CbGpPWpGaD
Boceprevir—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000132	0.000524	CcSEcCtD
Boceprevir—Hypertension—Prednisone—multiple sclerosis	0.000132	0.000523	CcSEcCtD
Boceprevir—Rash—Mitoxantrone—multiple sclerosis	0.000132	0.000523	CcSEcCtD
Boceprevir—Dermatitis—Mitoxantrone—multiple sclerosis	0.000132	0.000522	CcSEcCtD
Boceprevir—Chills—Methotrexate—multiple sclerosis	0.000132	0.000522	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—HLA-B—multiple sclerosis	0.000131	0.000572	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000131	0.000572	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CD8A—multiple sclerosis	0.000131	0.000571	CbGpPWpGaD
Boceprevir—Headache—Mitoxantrone—multiple sclerosis	0.000131	0.000519	CcSEcCtD
Boceprevir—CTSS—Toll-Like Receptors Cascades—IL6—multiple sclerosis	0.000131	0.000571	CbGpPWpGaD
Boceprevir—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000131	0.000517	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000131	0.000517	CcSEcCtD
Boceprevir—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.00013	0.000568	CbGpPWpGaD
Boceprevir—Myalgia—Prednisone—multiple sclerosis	0.00013	0.000515	CcSEcCtD
Boceprevir—Arthralgia—Prednisone—multiple sclerosis	0.00013	0.000515	CcSEcCtD
Boceprevir—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00013	0.000515	CcSEcCtD
Boceprevir—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00013	0.000514	CcSEcCtD
Boceprevir—Anxiety—Prednisone—multiple sclerosis	0.00013	0.000514	CcSEcCtD
Boceprevir—Alopecia—Methotrexate—multiple sclerosis	0.00013	0.000514	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—HLA-DRB1—multiple sclerosis	0.00013	0.000565	CbGpPWpGaD
Boceprevir—Insomnia—Betamethasone—multiple sclerosis	0.00013	0.000513	CcSEcCtD
Boceprevir—Insomnia—Dexamethasone—multiple sclerosis	0.00013	0.000513	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000129	0.000512	CcSEcCtD
Boceprevir—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000129	0.00051	CcSEcCtD
Boceprevir—Paraesthesia—Dexamethasone—multiple sclerosis	0.000129	0.000509	CcSEcCtD
Boceprevir—Paraesthesia—Betamethasone—multiple sclerosis	0.000129	0.000509	CcSEcCtD
Boceprevir—Discomfort—Prednisone—multiple sclerosis	0.000129	0.000509	CcSEcCtD
Boceprevir—Mental disorder—Methotrexate—multiple sclerosis	0.000129	0.000509	CcSEcCtD
Boceprevir—CTSS—Immune System—TNFAIP3—multiple sclerosis	0.000128	0.000557	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—TGFB1—multiple sclerosis	0.000128	0.000557	CbGpPWpGaD
Boceprevir—Malnutrition—Methotrexate—multiple sclerosis	0.000128	0.000506	CcSEcCtD
Boceprevir—Erythema—Methotrexate—multiple sclerosis	0.000128	0.000506	CcSEcCtD
Boceprevir—CTSS—Extracellular matrix organization—MMP9—multiple sclerosis	0.000128	0.000556	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CD40—multiple sclerosis	0.000127	0.000555	CbGpPWpGaD
Boceprevir—CTSK—Immune System—ITGA4—multiple sclerosis	0.000127	0.000555	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—TYK2—multiple sclerosis	0.000127	0.000554	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—TYK2—multiple sclerosis	0.000127	0.000554	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IFNB1—multiple sclerosis	0.000127	0.000551	CbGpPWpGaD
Boceprevir—Hypersensitivity—Prednisolone—multiple sclerosis	0.000127	0.000501	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	0.000127	0.000551	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—HLA-B—multiple sclerosis	0.000126	0.00055	CbGpPWpGaD
Boceprevir—Dyspepsia—Betamethasone—multiple sclerosis	0.000126	0.000499	CcSEcCtD
Boceprevir—Dyspepsia—Dexamethasone—multiple sclerosis	0.000126	0.000499	CcSEcCtD
Boceprevir—CTSK—Immune System—CTLA4—multiple sclerosis	0.000126	0.000547	CbGpPWpGaD
Boceprevir—Urticaria—Triamcinolone—multiple sclerosis	0.000125	0.000497	CcSEcCtD
Boceprevir—Urticaria—Methylprednisolone—multiple sclerosis	0.000125	0.000496	CcSEcCtD
Boceprevir—Dysgeusia—Methotrexate—multiple sclerosis	0.000125	0.000495	CcSEcCtD
Boceprevir—CTSV—Immune System—HLA-DQB1—multiple sclerosis	0.000125	0.000544	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HLA-DQB1—multiple sclerosis	0.000125	0.000544	CbGpPWpGaD
Boceprevir—Body temperature increased—Triamcinolone—multiple sclerosis	0.000125	0.000494	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—CD80—multiple sclerosis	0.000125	0.000544	CbGpPWpGaD
Boceprevir—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000125	0.000493	CcSEcCtD
Boceprevir—Decreased appetite—Betamethasone—multiple sclerosis	0.000125	0.000493	CcSEcCtD
Boceprevir—Decreased appetite—Dexamethasone—multiple sclerosis	0.000125	0.000493	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—ICAM1—multiple sclerosis	0.000125	0.000542	CbGpPWpGaD
Boceprevir—Nausea—Mitoxantrone—multiple sclerosis	0.000124	0.000492	CcSEcCtD
Boceprevir—Infection—Prednisone—multiple sclerosis	0.000124	0.000491	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000124	0.00049	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000124	0.00049	CcSEcCtD
Boceprevir—Back pain—Methotrexate—multiple sclerosis	0.000124	0.000489	CcSEcCtD
Boceprevir—Fatigue—Dexamethasone—multiple sclerosis	0.000124	0.000489	CcSEcCtD
Boceprevir—Fatigue—Betamethasone—multiple sclerosis	0.000124	0.000489	CcSEcCtD
Boceprevir—Shock—Prednisone—multiple sclerosis	0.000123	0.000486	CcSEcCtD
Boceprevir—Pain—Betamethasone—multiple sclerosis	0.000123	0.000485	CcSEcCtD
Boceprevir—Pain—Dexamethasone—multiple sclerosis	0.000123	0.000485	CcSEcCtD
Boceprevir—Nervous system disorder—Prednisone—multiple sclerosis	0.000122	0.000485	CcSEcCtD
Boceprevir—Tachycardia—Prednisone—multiple sclerosis	0.000122	0.000482	CcSEcCtD
Boceprevir—Skin disorder—Prednisone—multiple sclerosis	0.000121	0.00048	CcSEcCtD
Boceprevir—Hyperhidrosis—Prednisone—multiple sclerosis	0.000121	0.000478	CcSEcCtD
Boceprevir—Vision blurred—Methotrexate—multiple sclerosis	0.00012	0.000477	CcSEcCtD
Boceprevir—CTSL—Immune System—CD86—multiple sclerosis	0.00012	0.000524	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD86—multiple sclerosis	0.00012	0.000524	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—CD80—multiple sclerosis	0.00012	0.000522	CbGpPWpGaD
Boceprevir—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000119	0.000469	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	0.000118	0.000515	CbGpPWpGaD
Boceprevir—Anaemia—Methotrexate—multiple sclerosis	0.000118	0.000468	CcSEcCtD
Boceprevir—Feeling abnormal—Betamethasone—multiple sclerosis	0.000118	0.000468	CcSEcCtD
Boceprevir—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000118	0.000468	CcSEcCtD
Boceprevir—CTSL—Immune System—CD40LG—multiple sclerosis	0.000118	0.000514	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD40LG—multiple sclerosis	0.000118	0.000514	CbGpPWpGaD
Boceprevir—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000117	0.000464	CcSEcCtD
Boceprevir—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000117	0.000464	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—HLA-A—multiple sclerosis	0.000117	0.000509	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD8A—multiple sclerosis	0.000117	0.000508	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD8A—multiple sclerosis	0.000117	0.000508	CbGpPWpGaD
Boceprevir—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000116	0.000461	CcSEcCtD
Boceprevir—CMA1—Metabolism of proteins—POMC—multiple sclerosis	0.000116	0.000506	CbGpPWpGaD
Boceprevir—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000116	0.00046	CcSEcCtD
Boceprevir—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000116	0.000506	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000116	0.000506	CbGpPWpGaD
Boceprevir—Malaise—Methotrexate—multiple sclerosis	0.000115	0.000456	CcSEcCtD
Boceprevir—CTSS—Immune System—CD28—multiple sclerosis	0.000115	0.000501	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CD4—multiple sclerosis	0.000115	0.000501	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—CD4—multiple sclerosis	0.000115	0.000501	CbGpPWpGaD
Boceprevir—Vertigo—Methotrexate—multiple sclerosis	0.000115	0.000455	CcSEcCtD
Boceprevir—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000114	0.000499	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000114	0.000499	CbGpPWpGaD
Boceprevir—Leukopenia—Methotrexate—multiple sclerosis	0.000114	0.000453	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—CD86—multiple sclerosis	0.000114	0.000496	CbGpPWpGaD
Boceprevir—Urticaria—Betamethasone—multiple sclerosis	0.000114	0.000451	CcSEcCtD
Boceprevir—Urticaria—Dexamethasone—multiple sclerosis	0.000114	0.000451	CcSEcCtD
Boceprevir—CMA1—Metabolism of proteins—CCL2—multiple sclerosis	0.000114	0.000496	CbGpPWpGaD
Boceprevir—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000114	0.00045	CcSEcCtD
Boceprevir—Dizziness—Prednisolone—multiple sclerosis	0.000114	0.00045	CcSEcCtD
Boceprevir—Asthenia—Triamcinolone—multiple sclerosis	0.000113	0.000449	CcSEcCtD
Boceprevir—Body temperature increased—Betamethasone—multiple sclerosis	0.000113	0.000449	CcSEcCtD
Boceprevir—Body temperature increased—Dexamethasone—multiple sclerosis	0.000113	0.000449	CcSEcCtD
Boceprevir—Abdominal pain—Dexamethasone—multiple sclerosis	0.000113	0.000449	CcSEcCtD
Boceprevir—Abdominal pain—Betamethasone—multiple sclerosis	0.000113	0.000449	CcSEcCtD
Boceprevir—Asthenia—Methylprednisolone—multiple sclerosis	0.000113	0.000448	CcSEcCtD
Boceprevir—CTSS—Immune System—PTPRC—multiple sclerosis	0.000113	0.000492	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CCR2—multiple sclerosis	0.000113	0.000492	CbGpPWpGaD
Boceprevir—Insomnia—Prednisone—multiple sclerosis	0.000113	0.000447	CcSEcCtD
Boceprevir—CTSL—Immune System—HLA-B—multiple sclerosis	0.000112	0.000489	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HLA-B—multiple sclerosis	0.000112	0.000489	CbGpPWpGaD
Boceprevir—Paraesthesia—Prednisone—multiple sclerosis	0.000112	0.000444	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—IL10—multiple sclerosis	0.000112	0.000487	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	0.000112	0.000487	CbGpPWpGaD
Boceprevir—Pruritus—Triamcinolone—multiple sclerosis	0.000112	0.000442	CcSEcCtD
Boceprevir—Cough—Methotrexate—multiple sclerosis	0.000112	0.000442	CcSEcCtD
Boceprevir—Pruritus—Methylprednisolone—multiple sclerosis	0.000111	0.000441	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—TLR4—multiple sclerosis	0.000111	0.000485	CbGpPWpGaD
Boceprevir—CTSK—Immune System—VCAM1—multiple sclerosis	0.000111	0.000483	CbGpPWpGaD
Boceprevir—CTSK—Immune System—HLA-DQA1—multiple sclerosis	0.000111	0.000482	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CD4—multiple sclerosis	0.00011	0.000481	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CD4—multiple sclerosis	0.00011	0.000481	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCL3—multiple sclerosis	0.00011	0.000479	CbGpPWpGaD
Boceprevir—Dyspepsia—Prednisone—multiple sclerosis	0.00011	0.000435	CcSEcCtD
Boceprevir—CTSS—Immune System—HLA-DPB1—multiple sclerosis	0.000109	0.000475	CbGpPWpGaD
Boceprevir—Chest pain—Methotrexate—multiple sclerosis	0.000109	0.000431	CcSEcCtD
Boceprevir—Arthralgia—Methotrexate—multiple sclerosis	0.000109	0.000431	CcSEcCtD
Boceprevir—Myalgia—Methotrexate—multiple sclerosis	0.000109	0.000431	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—IL4—multiple sclerosis	0.000109	0.000474	CbGpPWpGaD
Boceprevir—Decreased appetite—Prednisone—multiple sclerosis	0.000108	0.00043	CcSEcCtD
Boceprevir—Rash—Prednisolone—multiple sclerosis	0.000108	0.000429	CcSEcCtD
Boceprevir—Dermatitis—Prednisolone—multiple sclerosis	0.000108	0.000428	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000108	0.000428	CcSEcCtD
Boceprevir—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000108	0.000427	CcSEcCtD
Boceprevir—Fatigue—Prednisone—multiple sclerosis	0.000108	0.000426	CcSEcCtD
Boceprevir—Headache—Prednisolone—multiple sclerosis	0.000108	0.000426	CcSEcCtD
Boceprevir—Discomfort—Methotrexate—multiple sclerosis	0.000107	0.000426	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—HLA-DRB1—multiple sclerosis	0.000107	0.000465	CbGpPWpGaD
Boceprevir—Constipation—Prednisone—multiple sclerosis	0.000107	0.000423	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	0.000106	0.000463	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PTGER4—multiple sclerosis	0.000106	0.000461	CbGpPWpGaD
Boceprevir—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000106	0.000461	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—TYK2—multiple sclerosis	0.000105	0.000459	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—TGFB1—multiple sclerosis	0.000105	0.000459	CbGpPWpGaD
Boceprevir—Confusional state—Methotrexate—multiple sclerosis	0.000105	0.000416	CcSEcCtD
Boceprevir—CTSV—Immune System—IL2RA—multiple sclerosis	0.000105	0.000458	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL2RA—multiple sclerosis	0.000105	0.000458	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CD40—multiple sclerosis	0.000105	0.000457	CbGpPWpGaD
Boceprevir—CTSS—Immune System—ITGA4—multiple sclerosis	0.000105	0.000457	CbGpPWpGaD
Boceprevir—Dizziness—Triamcinolone—multiple sclerosis	0.000104	0.000413	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—PGR—multiple sclerosis	0.000104	0.000454	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IFNB1—multiple sclerosis	0.000104	0.000454	CbGpPWpGaD
Boceprevir—Dizziness—Methylprednisolone—multiple sclerosis	0.000104	0.000413	CcSEcCtD
Boceprevir—CTSL—Immune System—HLA-A—multiple sclerosis	0.000104	0.000453	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HLA-A—multiple sclerosis	0.000104	0.000453	CbGpPWpGaD
Boceprevir—Infection—Methotrexate—multiple sclerosis	0.000104	0.00041	CcSEcCtD
Boceprevir—CTSS—Immune System—CTLA4—multiple sclerosis	0.000103	0.000451	CbGpPWpGaD
Boceprevir—CTSK—Immune System—HLA-DQB1—multiple sclerosis	0.000103	0.000451	CbGpPWpGaD
Boceprevir—Feeling abnormal—Prednisone—multiple sclerosis	0.000103	0.000407	CcSEcCtD
Boceprevir—Asthenia—Betamethasone—multiple sclerosis	0.000103	0.000407	CcSEcCtD
Boceprevir—Asthenia—Dexamethasone—multiple sclerosis	0.000103	0.000407	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—CD80—multiple sclerosis	0.000103	0.000448	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—ICAM1—multiple sclerosis	0.000103	0.000447	CbGpPWpGaD
Boceprevir—Nervous system disorder—Methotrexate—multiple sclerosis	0.000102	0.000405	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—CXCR3—multiple sclerosis	0.000102	0.000445	CbGpPWpGaD
Boceprevir—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000102	0.000404	CcSEcCtD
Boceprevir—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000102	0.000404	CcSEcCtD
Boceprevir—Nausea—Prednisolone—multiple sclerosis	0.000102	0.000404	CcSEcCtD
Boceprevir—Pruritus—Dexamethasone—multiple sclerosis	0.000101	0.000401	CcSEcCtD
Boceprevir—Pruritus—Betamethasone—multiple sclerosis	0.000101	0.000401	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—CD28—multiple sclerosis	0.000101	0.000441	CbGpPWpGaD
Boceprevir—Skin disorder—Methotrexate—multiple sclerosis	0.000101	0.000401	CcSEcCtD
Boceprevir—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000101	0.000399	CcSEcCtD
Boceprevir—Vomiting—Triamcinolone—multiple sclerosis	0.0001	0.000398	CcSEcCtD
Boceprevir—Vomiting—Methylprednisolone—multiple sclerosis	0.0001	0.000397	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—FAS—multiple sclerosis	0.0001	0.000436	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CD86—multiple sclerosis	9.96e-05	0.000434	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	9.96e-05	0.000434	CbGpPWpGaD
Boceprevir—Rash—Triamcinolone—multiple sclerosis	9.96e-05	0.000394	CcSEcCtD
Boceprevir—Dermatitis—Triamcinolone—multiple sclerosis	9.95e-05	0.000394	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—CCR2—multiple sclerosis	9.95e-05	0.000433	CbGpPWpGaD
Boceprevir—Rash—Methylprednisolone—multiple sclerosis	9.94e-05	0.000393	CcSEcCtD
Boceprevir—Dermatitis—Methylprednisolone—multiple sclerosis	9.93e-05	0.000393	CcSEcCtD
Boceprevir—Urticaria—Prednisone—multiple sclerosis	9.91e-05	0.000393	CcSEcCtD
Boceprevir—Headache—Triamcinolone—multiple sclerosis	9.89e-05	0.000392	CcSEcCtD
Boceprevir—Headache—Methylprednisolone—multiple sclerosis	9.87e-05	0.000391	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—CD80—multiple sclerosis	9.87e-05	0.00043	CbGpPWpGaD
Boceprevir—Body temperature increased—Prednisone—multiple sclerosis	9.87e-05	0.000391	CcSEcCtD
Boceprevir—Abdominal pain—Prednisone—multiple sclerosis	9.87e-05	0.000391	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	9.85e-05	0.000429	CbGpPWpGaD
Boceprevir—Diarrhoea—Betamethasone—multiple sclerosis	9.8e-05	0.000388	CcSEcCtD
Boceprevir—Diarrhoea—Dexamethasone—multiple sclerosis	9.8e-05	0.000388	CcSEcCtD
Boceprevir—CTSK—Immune System—CD40LG—multiple sclerosis	9.77e-05	0.000426	CbGpPWpGaD
Boceprevir—Hypotension—Methotrexate—multiple sclerosis	9.75e-05	0.000386	CcSEcCtD
Boceprevir—CTSK—Immune System—CD8A—multiple sclerosis	9.66e-05	0.000421	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CD4—multiple sclerosis	9.53e-05	0.000415	CbGpPWpGaD
Boceprevir—CTSV—Immune System—TLR4—multiple sclerosis	9.51e-05	0.000414	CbGpPWpGaD
Boceprevir—CTSL—Immune System—TLR4—multiple sclerosis	9.51e-05	0.000414	CbGpPWpGaD
Boceprevir—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	9.5e-05	0.000376	CcSEcCtD
Boceprevir—CTSV—Immune System—HLA-DRB1—multiple sclerosis	9.5e-05	0.000414	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HLA-DRB1—multiple sclerosis	9.5e-05	0.000414	CbGpPWpGaD
Boceprevir—Dizziness—Betamethasone—multiple sclerosis	9.48e-05	0.000375	CcSEcCtD
Boceprevir—Dizziness—Dexamethasone—multiple sclerosis	9.48e-05	0.000375	CcSEcCtD
Boceprevir—Insomnia—Methotrexate—multiple sclerosis	9.43e-05	0.000373	CcSEcCtD
Boceprevir—Nausea—Triamcinolone—multiple sclerosis	9.38e-05	0.000371	CcSEcCtD
Boceprevir—Paraesthesia—Methotrexate—multiple sclerosis	9.37e-05	0.000371	CcSEcCtD
Boceprevir—Nausea—Methylprednisolone—multiple sclerosis	9.36e-05	0.000371	CcSEcCtD
Boceprevir—Dyspnoea—Methotrexate—multiple sclerosis	9.3e-05	0.000368	CcSEcCtD
Boceprevir—CTSK—Immune System—HLA-B—multiple sclerosis	9.29e-05	0.000405	CbGpPWpGaD
Boceprevir—Hypersensitivity—Prednisone—multiple sclerosis	9.19e-05	0.000364	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—CNR1—multiple sclerosis	9.18e-05	0.0004	CbGpPWpGaD
Boceprevir—Dyspepsia—Methotrexate—multiple sclerosis	9.18e-05	0.000363	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—CD4—multiple sclerosis	9.15e-05	0.000399	CbGpPWpGaD
Boceprevir—CTSS—Immune System—VCAM1—multiple sclerosis	9.13e-05	0.000398	CbGpPWpGaD
Boceprevir—CTSV—Immune System—ICAM1—multiple sclerosis	9.11e-05	0.000397	CbGpPWpGaD
Boceprevir—CTSL—Immune System—ICAM1—multiple sclerosis	9.11e-05	0.000397	CbGpPWpGaD
Boceprevir—Vomiting—Dexamethasone—multiple sclerosis	9.11e-05	0.000361	CcSEcCtD
Boceprevir—Vomiting—Betamethasone—multiple sclerosis	9.11e-05	0.000361	CcSEcCtD
Boceprevir—CTSS—Immune System—HLA-DQA1—multiple sclerosis	9.11e-05	0.000397	CbGpPWpGaD
Boceprevir—Decreased appetite—Methotrexate—multiple sclerosis	9.07e-05	0.000359	CcSEcCtD
Boceprevir—Rash—Betamethasone—multiple sclerosis	9.04e-05	0.000358	CcSEcCtD
Boceprevir—Rash—Dexamethasone—multiple sclerosis	9.04e-05	0.000358	CcSEcCtD
Boceprevir—Dermatitis—Betamethasone—multiple sclerosis	9.03e-05	0.000357	CcSEcCtD
Boceprevir—Dermatitis—Dexamethasone—multiple sclerosis	9.03e-05	0.000357	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Methotrexate—multiple sclerosis	9e-05	0.000356	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	9e-05	0.000392	CbGpPWpGaD
Boceprevir—Fatigue—Methotrexate—multiple sclerosis	8.99e-05	0.000356	CcSEcCtD
Boceprevir—Headache—Dexamethasone—multiple sclerosis	8.98e-05	0.000355	CcSEcCtD
Boceprevir—Headache—Betamethasone—multiple sclerosis	8.98e-05	0.000355	CcSEcCtD
Boceprevir—Asthenia—Prednisone—multiple sclerosis	8.95e-05	0.000355	CcSEcCtD
Boceprevir—Pain—Methotrexate—multiple sclerosis	8.92e-05	0.000353	CcSEcCtD
Boceprevir—Pruritus—Prednisone—multiple sclerosis	8.83e-05	0.00035	CcSEcCtD
Boceprevir—CTSL—Immune System—CD80—multiple sclerosis	8.77e-05	0.000382	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD80—multiple sclerosis	8.77e-05	0.000382	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL2RA—multiple sclerosis	8.71e-05	0.000379	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—TYK2—multiple sclerosis	8.68e-05	0.000378	CbGpPWpGaD
Boceprevir—CTSK—Immune System—HLA-A—multiple sclerosis	8.61e-05	0.000375	CbGpPWpGaD
Boceprevir—Feeling abnormal—Methotrexate—multiple sclerosis	8.59e-05	0.00034	CcSEcCtD
Boceprevir—Diarrhoea—Prednisone—multiple sclerosis	8.54e-05	0.000338	CcSEcCtD
Boceprevir—Gastrointestinal pain—Methotrexate—multiple sclerosis	8.53e-05	0.000338	CcSEcCtD
Boceprevir—CTSS—Immune System—HLA-DQB1—multiple sclerosis	8.52e-05	0.000371	CbGpPWpGaD
Boceprevir—Nausea—Betamethasone—multiple sclerosis	8.51e-05	0.000337	CcSEcCtD
Boceprevir—Nausea—Dexamethasone—multiple sclerosis	8.51e-05	0.000337	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—CD80—multiple sclerosis	8.31e-05	0.000362	CbGpPWpGaD
Boceprevir—Urticaria—Methotrexate—multiple sclerosis	8.29e-05	0.000328	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—CXCL10—multiple sclerosis	8.27e-05	0.00036	CbGpPWpGaD
Boceprevir—Dizziness—Prednisone—multiple sclerosis	8.25e-05	0.000327	CcSEcCtD
Boceprevir—Body temperature increased—Methotrexate—multiple sclerosis	8.24e-05	0.000326	CcSEcCtD
Boceprevir—Abdominal pain—Methotrexate—multiple sclerosis	8.24e-05	0.000326	CcSEcCtD
Boceprevir—CTSS—Immune System—CD86—multiple sclerosis	8.21e-05	0.000357	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—MAPK1—multiple sclerosis	8.09e-05	0.000353	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—MAPK1—multiple sclerosis	8.09e-05	0.000353	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CD40LG—multiple sclerosis	8.05e-05	0.000351	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CD8A—multiple sclerosis	7.96e-05	0.000347	CbGpPWpGaD
Boceprevir—Vomiting—Prednisone—multiple sclerosis	7.93e-05	0.000314	CcSEcCtD
Boceprevir—CTSK—Immune System—TLR4—multiple sclerosis	7.88e-05	0.000343	CbGpPWpGaD
Boceprevir—Rash—Prednisone—multiple sclerosis	7.87e-05	0.000312	CcSEcCtD
Boceprevir—CTSK—Immune System—HLA-DRB1—multiple sclerosis	7.87e-05	0.000343	CbGpPWpGaD
Boceprevir—Dermatitis—Prednisone—multiple sclerosis	7.86e-05	0.000311	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—CD4—multiple sclerosis	7.85e-05	0.000342	CbGpPWpGaD
Boceprevir—Headache—Prednisone—multiple sclerosis	7.82e-05	0.00031	CcSEcCtD
Boceprevir—Hypersensitivity—Methotrexate—multiple sclerosis	7.68e-05	0.000304	CcSEcCtD
Boceprevir—CTSS—Immune System—HLA-B—multiple sclerosis	7.65e-05	0.000333	CbGpPWpGaD
Boceprevir—CTSK—Immune System—ICAM1—multiple sclerosis	7.55e-05	0.000329	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CD4—multiple sclerosis	7.53e-05	0.000328	CbGpPWpGaD
Boceprevir—Asthenia—Methotrexate—multiple sclerosis	7.48e-05	0.000296	CcSEcCtD
Boceprevir—Nausea—Prednisone—multiple sclerosis	7.41e-05	0.000293	CcSEcCtD
Boceprevir—CTSV—Immune System—TYK2—multiple sclerosis	7.41e-05	0.000323	CbGpPWpGaD
Boceprevir—CTSL—Immune System—TYK2—multiple sclerosis	7.41e-05	0.000323	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	7.4e-05	0.000322	CbGpPWpGaD
Boceprevir—Pruritus—Methotrexate—multiple sclerosis	7.38e-05	0.000292	CcSEcCtD
Boceprevir—CTSK—Immune System—CD80—multiple sclerosis	7.27e-05	0.000317	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CD86—multiple sclerosis	7.23e-05	0.000315	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	7.2e-05	0.000313	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL2RA—multiple sclerosis	7.17e-05	0.000312	CbGpPWpGaD
Boceprevir—Diarrhoea—Methotrexate—multiple sclerosis	7.14e-05	0.000283	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—CCL5—multiple sclerosis	7.12e-05	0.00031	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HLA-A—multiple sclerosis	7.09e-05	0.000309	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IFNG—multiple sclerosis	6.93e-05	0.000302	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IFNG—multiple sclerosis	6.93e-05	0.000302	CbGpPWpGaD
Boceprevir—Dizziness—Methotrexate—multiple sclerosis	6.9e-05	0.000273	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—MAPK1—multiple sclerosis	6.71e-05	0.000292	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD4—multiple sclerosis	6.7e-05	0.000292	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD4—multiple sclerosis	6.7e-05	0.000292	CbGpPWpGaD
Boceprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	6.69e-05	0.000291	CbGpPWpGaD
Boceprevir—Vomiting—Methotrexate—multiple sclerosis	6.63e-05	0.000263	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—SPP1—multiple sclerosis	6.59e-05	0.000287	CbGpPWpGaD
Boceprevir—Rash—Methotrexate—multiple sclerosis	6.58e-05	0.00026	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	6.57e-05	0.000286	CbGpPWpGaD
Boceprevir—Dermatitis—Methotrexate—multiple sclerosis	6.57e-05	0.00026	CcSEcCtD
Boceprevir—Headache—Methotrexate—multiple sclerosis	6.53e-05	0.000259	CcSEcCtD
Boceprevir—CTSS—Immune System—TLR4—multiple sclerosis	6.49e-05	0.000283	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HLA-DRB1—multiple sclerosis	6.48e-05	0.000282	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCR5—multiple sclerosis	6.41e-05	0.000279	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL2RA—multiple sclerosis	6.32e-05	0.000275	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—IL6—multiple sclerosis	6.22e-05	0.000271	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—IL6—multiple sclerosis	6.22e-05	0.000271	CbGpPWpGaD
Boceprevir—CTSS—Immune System—ICAM1—multiple sclerosis	6.22e-05	0.000271	CbGpPWpGaD
Boceprevir—Nausea—Methotrexate—multiple sclerosis	6.2e-05	0.000245	CcSEcCtD
Boceprevir—CTSV—Immune System—IL1B—multiple sclerosis	6.19e-05	0.000269	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL1B—multiple sclerosis	6.19e-05	0.000269	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL2—multiple sclerosis	6.16e-05	0.000268	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL2—multiple sclerosis	6.16e-05	0.000268	CbGpPWpGaD
Boceprevir—CTSK—Immune System—TYK2—multiple sclerosis	6.14e-05	0.000267	CbGpPWpGaD
Boceprevir—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.06e-05	0.000264	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SRM—multiple sclerosis	6.06e-05	0.000264	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CD80—multiple sclerosis	5.99e-05	0.000261	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	5.86e-05	0.000255	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL2—multiple sclerosis	5.84e-05	0.000254	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—APOE—multiple sclerosis	5.83e-05	0.000254	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	5.78e-05	0.000252	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IFNG—multiple sclerosis	5.75e-05	0.00025	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—POMC—multiple sclerosis	5.62e-05	0.000245	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.61e-05	0.000244	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CD4—multiple sclerosis	5.55e-05	0.000242	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—MAPK1—multiple sclerosis	5.52e-05	0.000241	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CD80—multiple sclerosis	5.27e-05	0.00023	CbGpPWpGaD
Boceprevir—CTSV—Immune System—STAT3—multiple sclerosis	5.19e-05	0.000226	CbGpPWpGaD
Boceprevir—CTSL—Immune System—STAT3—multiple sclerosis	5.19e-05	0.000226	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—IL6—multiple sclerosis	5.15e-05	0.000224	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL1B—multiple sclerosis	5.13e-05	0.000223	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL2—multiple sclerosis	5.11e-05	0.000222	CbGpPWpGaD
Boceprevir—CTSS—Immune System—TYK2—multiple sclerosis	5.05e-05	0.00022	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—POMC—multiple sclerosis	5.01e-05	0.000218	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	4.94e-05	0.000215	CbGpPWpGaD
Boceprevir—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.92e-05	0.000214	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCL2—multiple sclerosis	4.9e-05	0.000214	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IFNG—multiple sclerosis	4.73e-05	0.000206	CbGpPWpGaD
Boceprevir—CTSV—Immune System—MAPK1—multiple sclerosis	4.71e-05	0.000205	CbGpPWpGaD
Boceprevir—CTSL—Immune System—MAPK1—multiple sclerosis	4.71e-05	0.000205	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SRM—multiple sclerosis	4.57e-05	0.000199	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CD4—multiple sclerosis	4.57e-05	0.000199	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	4.55e-05	0.000198	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TYK2—multiple sclerosis	4.45e-05	0.000194	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.43e-05	0.000193	CbGpPWpGaD
Boceprevir—CTSK—Immune System—STAT3—multiple sclerosis	4.3e-05	0.000187	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	4.27e-05	0.000186	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	4.27e-05	0.000186	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—TNF—multiple sclerosis	4.25e-05	0.000185	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—IL6—multiple sclerosis	4.24e-05	0.000185	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL1B—multiple sclerosis	4.22e-05	0.000184	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL2—multiple sclerosis	4.2e-05	0.000183	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.92e-05	0.000171	CbGpPWpGaD
Boceprevir—CTSK—Immune System—MAPK1—multiple sclerosis	3.91e-05	0.00017	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GPC5—multiple sclerosis	3.91e-05	0.00017	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL2—multiple sclerosis	3.7e-05	0.000161	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL6—multiple sclerosis	3.62e-05	0.000158	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL6—multiple sclerosis	3.62e-05	0.000158	CbGpPWpGaD
Boceprevir—CTSS—Immune System—STAT3—multiple sclerosis	3.54e-05	0.000154	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MMP9—multiple sclerosis	3.51e-05	0.000153	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—RRM1—multiple sclerosis	3.24e-05	0.000141	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP24A1—multiple sclerosis	3.22e-05	0.00014	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP27B1—multiple sclerosis	3.22e-05	0.00014	CbGpPWpGaD
Boceprevir—CTSS—Immune System—MAPK1—multiple sclerosis	3.22e-05	0.00014	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—STAT3—multiple sclerosis	3.12e-05	0.000136	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL6—multiple sclerosis	3e-05	0.000131	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GPC5—multiple sclerosis	2.95e-05	0.000128	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MYC—multiple sclerosis	2.9e-05	0.000126	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TGFB1—multiple sclerosis	2.89e-05	0.000126	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MAPK1—multiple sclerosis	2.83e-05	0.000123	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SRM—multiple sclerosis	2.82e-05	0.000123	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.61e-05	0.000114	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL6—multiple sclerosis	2.47e-05	0.000108	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—RRM1—multiple sclerosis	2.44e-05	0.000106	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.25e-05	9.82e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.25e-05	9.79e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.2e-05	9.6e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL6—multiple sclerosis	2.18e-05	9.48e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.1e-05	9.14e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.99e-05	8.65e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.99e-05	8.65e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.86e-05	8.1e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.82e-05	7.91e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.5e-05	6.55e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.41e-05	6.15e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—BCHE—multiple sclerosis	1.4e-05	6.11e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—APOE—multiple sclerosis	1.12e-05	4.87e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—POMC—multiple sclerosis	9.61e-06	4.18e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALB—multiple sclerosis	8.76e-06	3.82e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—BCHE—multiple sclerosis	8.64e-06	3.76e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—APOE—multiple sclerosis	8.44e-06	3.68e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—POMC—multiple sclerosis	7.25e-06	3.16e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALB—multiple sclerosis	6.61e-06	2.88e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—APOE—multiple sclerosis	5.2e-06	2.26e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—POMC—multiple sclerosis	4.47e-06	1.95e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALB—multiple sclerosis	4.07e-06	1.77e-05	CbGpPWpGaD
